Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMUGENE LIMITED Capital/Financing Update 2021

Jul 8, 2021

65124_rns_2021-07-08_515313a2-6dc7-45fe-b07e-e2232091d5da.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

ABN: 99 009 179 551

==> picture [168 x 61] intentionally omitted <==

09 July 2021

ASX ANNOUNCEMENT

Notice Under Section 708A(5) of the Corporations Act 2001

[ASX Code: IMU]

This notice is given under paragraph (5)(e) of section 708A of the Corporations Act 2001 .

Type: Shares
Class/description: Ordinary
ASX code: IMU
Date of issue: 09 July 2021
Number issued: 25,183,871
$0.0155 (as per the announcement
Issue price per security: ‘Issuance of Milestone Shares under
Vaxinia acquisition’ on 09 July 2021).

Accordingly, the Company gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (the

" Corporations Act ") that:

  1. the abovementioned ordinary shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act ;

  2. as at the date of this notice the Company has complied with:

    • (i) the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and

    • (ii) section 674 of the Corporations Act ; and

  3. as at the date of this notice there is no "excluded information" (as defined in subsection 708A(7) of the Corporations Act ) which is required to be disclosed by the Company.

For and on behalf of the Company,

==> picture [66 x 51] intentionally omitted <==

Phillip Hains Company Secretary